Younger adult type 2 diabetic patients have poorer glycaemic control: a cross-sectional study in a primary care setting in Singapore

BMC Endocrine Disorders

Ee Guan Tay³  Choon How How³  Nan Luo²  Yan Ping Liu¹  Joanne Hui Min Quah³ 

[1] Merck Sharp & Dohme (I.A.) Corp, (Singapore Branch), Singapore, Singapore;Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore;SingHealth Polyclinics- Outram Polyclinic, 3 Second Hospital Avenue, Health Promotion Board building Level 2, Singapore 168937, Singapore

关键词: Singapore;    Primary health care;    Hemoglobin A glycosylated;    Diabetes mellitus type 2;   

Others  :  1085862
DOI  :  10.1186/1472-6823-13-18

 received in 2012-10-11, accepted in 2013-05-29,  发布年份 2013

【 摘 要 】

Background

The aim was to study the glycaemic control of type 2 diabetic patients, and to identify factors associated with unacceptable glycaemic control (defined as HbA_1c >8.0%).

Methods

Analysis of data collected in a cross-sectional survey of type 2 diabetic patients in eight SingHealth Polyclinics in January 2009. HbA_1c value was measured on the day of the survey, while information on patient and diabetic characteristics was obtained through a questionnaire. Odds ratio of having unacceptable glycaemic control was estimated for selected variables using multiple logistic regression models.

Results

A total of 688 patients were included in the analysis. The mean (± standard deviation) and median (range) HbA_1c levels were 7.6% (± 1.35) and 7.3% (5.0% to 14.0%), respectively. 25.4% of the patients had an unacceptable HbA_1c level of >8.0% and the odds of this were higher (p < 0.05) in patients with the following characteristics: younger age, longer diabetes duration, presence of insulin treatment, and poorer compliance to medication.

Conclusion

Younger adult patients were found to have poorer glycaemic control, and hence targeted educational and behaviour modification programmes would be required to effectively manage this group of patients.

【 授权许可】

   
2013 Quah et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Unwin N, Gan D, Whiting D: The IDF Diabetes Atlas: providing evidence, raising awareness and promoting action. Diabetes Res Clin Pract 2010, 87(1):2-3.
• [2]WHO: Global status report on noncommunicable diseases 2010. Geneva, Switzerland: World Health Organization; 2011.
• [3]Zimmet P, Alberti KG, Shaw J: Global and societal implications of the diabetes epidemic. Nature 2001, 414(6865):782-787.
• [4]Gerstein HC, Pogue J, Mann JF, Lonn E, Dagenais GR, McQueen M: The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis. Diabetologia 2005, 48(9):1749-1755.
• [5]Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000, 321(7258):405-412.
• [6]Goudswaard AN, Stolk RP, Zuithoff P, Rutten GE: Patient characteristics do not predict poor glycaemic control in type 2 diabetes patients treated in primary care. Eur J Epidemiol 2004, 19(6):541-545.
• [7]Ng TP, Goh LG, Tan Y, Tan E, Leong H, Tay EG: Ethnic differences in glycaemic control in adult Type 2 diabetic patients in primary care: a 3-year follow-up study. Diabet Med 2005, 22(11):1598-1604.
• [8]Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, Lafont S, Bergeonneau C, Kassai B: Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ 2011, 343:d4169.
• [9]National Health Survey: Ministry of Health Singapore Epidemiology and Disease Control Department. Epidemiology and disease control division, Ministry of Health, Republic of Singapore: National Health Survey 2010, Singapore; 2004. http://www.moh.gov.sg/content/dam/moh_web/Publications/Reports/2011/NHS2010%20-%20low%20res.pdf webcite
• [10]Health Facts Singapore 2010 Ministry of Health Singapore. Ministry of Health, Singapore: Singapore Health Facts, Principle Causes of Death; 2010. http://www.moh.gov.sg/content/moh_web/home/statistics/Health_Facts_Singapore/Principal_Causes_of_Death.html webcite
• [11]Clinical Practice Guidelines: Diabetes Mellitus. Ministry of Health, Singapore: Singapore Ministry of Health; 2006. http://www.moh.gov.sg/content/moh_web/healthprofessionalsportal/doctors/guidelines/cpg_medical.html webcite
• [12]Quah JH, Luo N, Ng WY, How CH, Tay EG: Health-related quality of life is associated with diabetic complications, but not with short-term diabetic control in primary care. Ann Acad Med Singapore 2011, 40(6):276-286.
• [13]Department of Statistics Singapore: Monthly Digest of Statistics. : Singapore Department of Statistics; 2010. http://www.singstat.gov.sg/publications/publications_and_papers/reference/monthly_digest.html webcite
• [14]HDB InfoWEB. cited; Available from: http://www.hdb.gov.sg/fi10/fi10320p.nsf/w/AboutUsHDBHistory?OpenDocument webcite
• [15]Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS: Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care 1999, 22(3):403-408.
• [16]Macisaac RJ, Jerums G, Weekes AJ, Thomas MC: Patterns of glycaemic control in Australian primary care (NEFRON 8). Intern Med J 2009, 39(8):512-518.
• [17]Lee HY, Wong WY: First year results of the medisave for chronic disease management program (CDMP). Ministry of Health, Singapore: Singapore Ministry of Health; 2007. http://www.moh.gov.sg/content/moh_web/home/Publications/information_papers/2008/first_year_resultsofthemedisaveforcdmp.html webcite
• [18]Bi Y, Zhu D, Cheng J, Zhu Y, Xu N, Cui S: The status of glycemic control: A cross-sectional study of outpatients with type 2 diabetes mellitus across primary, secondary, and tertiary hospitals in the Jiangsu province of China. Clin Ther 2010, 32(5):973-983.
• [19]Shorr RI, Franse LV, Resnick HE, Di Bari M, Johnson KC, Pahor M: Glycemic control of older adults with type 2 diabetes: findings from the third national health and nutrition examination survey, 1988–1994. J Am Geriatr Soc 2000, 48(3):264-267.
• [20]Blaum CS, Velez L, Hiss RG, Halter JB: Characteristics related to poor glycemic control in NIDDM patients in community practice. Diabetes Care 1997, 20(1):7-11.
• [21]Benoit SR, Fleming R, Philis-Tsimikas A, Ji M: Predictors of glycemic control among patients with Type 2 diabetes: a longitudinal study. BMC Publ Health 2005, 5:36. BioMed Central Full Text
• [22]El-Kebbi IM, Cook CB, Ziemer DC, Miller CD, Gallina DL, Phillips LS: Association of younger age with poor glycemic control and obesity in urban african americans with type 2 diabetes. Arch Intern Med 2003, 163(1):69-75.
• [23]Huppertz E, Pieper L, Klotsche J, Stridde E, Pittrow D, Bohler S: Diabetes mellitus in german primary care: quality of glycaemic control and subpopulations not well controlled - results of the DETECT study. Exp Clin Endocrinol Diabetes 2009, 117(1):6-14.
• [24]Song SH, Hardisty CA: Early onset type 2 diabetes mellitus: a harbinger for complications in later years–clinical observation from a secondary care cohort. QJM 2009, 102(11):799-806.
• [25]McWhinney IR, Freeman T: Textbook of Family Medicine. Third edition. 198 Madison Avenue, New York, New York 10016: Oxford University Press, Inc.; 2009:195.
• [26]Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA: 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008, 359(15):1577-1589.
• [27]Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005, 353(25):2643-2653.
• [28]Kavouras SA, Panagiotakos DB, Pitsavos C, Chrysohoou C, Anastasiou CA, Lentzas Y: Physical activity, obesity status, and glycemic control: The ATTICA study. Med Sci Sports Exerc 2007, 39(4):606-611.